Toronto Dominion Bank Novavax Inc Transaction History

Toronto Dominion Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$5.76 - $12.48 $120 - $262	21 New	21 $0
Q2 2022 Aug 11, 2022	SELL	$36.28 - $75.29 $557,297 - $1.16 Million	-15,361 Reduced 99.88%	19 $1,000
Q1 2022 May 09, 2022	BUY	$69.73 - $142.9 $99,434 - $203,775	1,426 Added 10.22%	15,380 $1.13 Million
Q4 2021 Feb 04, 2022	BUY	$134.56 - $217.97 $539,854 - $874,495	4,012 Added 40.35%	13,954 $2 Million
Q3 2021 Nov 08, 2021	SELL	$177.8 - $270.58 $16,891 - $25,705	-95 Reduced 0.95%	9,942 $2.06 Million
Q2 2021 Aug 13, 2021	BUY	$121.0 - $257.67 $1.21 Million - $2.59 Million	10,037 New	10,037 $2.13 Million

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

Stay updated on Toronto Dominion Bank with notifications on news.